Paper Details

  1. Home
  2. Paper Details

Netarsudil ophthalmic solution 0.02% for the treatment of patients with open-angle glaucoma or ocular hypertension.

Author: HeahT, KopczynskiC C

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Netarsudil ophthalmic solution 0.02% (Rhopressa) is a Rho kinase (ROCK) inhibitor approved for lowering elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Netarsudil effectively lowers IOP by increasing trabecular outflow and has a favorable safety profile with minimal systemic exposure.
Paper Details　
Original Abstract of the Article :
Once-daily (p.m.) netarsudil ophthalmic solution 0.02% (Rhopressa) is approved in the United States for lowering elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Netarsudil, a Rho kinase (ROCK) inhibitor that lowers IOP primarily by increasing trabecul...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1358/dot.2018.54.8.2849627

データ提供：米国国立医学図書館（NLM）

Netarsudil: A New Treatment Option for Open-Angle Glaucoma

Open-angle glaucoma is a common eye condition that can lead to vision loss. This study examines the efficacy and safety of netarsudil, a new medication for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

A New Tool for Glaucoma Management

The study demonstrates that netarsudil is effective in lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. This research provides valuable information about the potential benefits and risks of this new medication and offers a new tool for managing this eye condition.

Navigating the Treatment Landscape for Glaucoma

This study encourages continued research and development in the field of glaucoma treatment. Netarsudil offers a new and potentially effective option for patients. This research underscores the importance of personalized treatment plans, considering the individual needs of each patient.

Dr. Camel's Conclusion

This research is a testament to the ongoing progress in the field of ophthalmology. It's like finding a new oasis in the desert, offering hope and relief to those struggling with glaucoma. Netarsudil represents a new and potentially effective treatment option, providing a beacon of hope for individuals battling this challenging eye condition.
Date :
  1. Date Completed 2018-11-26
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

30209441

DOI: Digital Object Identifier

10.1358/dot.2018.54.8.2849627

Related Literature

Article Analysis
・Effects of netarsudil ophthalmic
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.